# An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

> **NCT05621746** · — · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 100 (estimated)

## Conditions studied

- Haemophilia A

## Interventions

- **DRUG:** Esperoct

## Key facts

- **NCT ID:** NCT05621746
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-23
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05621746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05621746, "An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05621746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*